FDA restricts Covid vaccine over safety issues

FDA restricts Covid vaccine over safety issues

When limiting the Johnson & Johnson’s Covid vaccine’s use to certain adults only, the US health regulator cited potentially dangerous side effects The US Food and Drug Administration (FDA) has limited its approval of Johnson & Johnson’s Covid vaccine to those over the age of 18, pointing to dangerous side effects observed in younger recipients.

Comments

Write a comment